Bahrain authorises use of Pfizer's anti-COVID drug
The decision was based on the review and evaluation of data provided by Pfizer
Last updated:
1 MIN READ
Manama: Bahrain's health authorities authorised Pfizer's Paxlovid COVID-19 drug for emergency use in adults aged over 18, the state news agency said in a statement on Saturday.
The decision by the National Authority for Regulating Health Professions and Services was based on the review and evaluation of data provided by Pfizer, the statement added.
Get Updates on Topics You Choose
Up Next
